ID   ARHGA_HUMAN             Reviewed;        1369 AA.
AC   O15013; O14665; Q2KHR8; Q68D55; Q8IWD9; Q8IY77;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   27-JUN-2006, sequence version 4.
DT   28-JUN-2023, entry version 184.
DE   RecName: Full=Rho guanine nucleotide exchange factor 10;
GN   Name=ARHGEF10; Synonyms=KIAA0294;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Duodenum, Prostate, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 353-1369 (ISOFORM 4).
RC   TISSUE=Brain;
RX   PubMed=9314494; DOI=10.1101/gr.7.9.887;
RA   Ranta S., Lehesjoki A.-E., de Fatima Bonaldo M., Knowles J.A.,
RA   Hirvasniemi A., Ross B., de Jong P.J., Soares M.B., de la Chapelle A.,
RA   Gilliam T.C.;
RT   "High-resolution mapping and transcript identification at the progressive
RT   epilepsy with mental retardation locus on chromosome 8p.";
RL   Genome Res. 7:887-896(1997).
RN   [7]
RP   FUNCTION, AND VARIANT SNCV ILE-357.
RX   PubMed=14508709; DOI=10.1086/378159;
RA   Verhoeven K., De Jonghe P., Van de Putte T., Nelis E., Zwijsen A.,
RA   Verpoorten N., De Vriendt E., Jacobs A., Van Gerwen V., Francis A.,
RA   Ceuterick C., Huylebroeck D., Timmerman V.;
RT   "Slowed conduction and thin myelination of peripheral nerves associated
RT   with mutant rho Guanine-nucleotide exchange factor 10.";
RL   Am. J. Hum. Genet. 73:926-932(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1287, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   METHYLATION AT GLN-1338, AND MUTAGENESIS OF GLN-1338.
RX   PubMed=26797129; DOI=10.1074/jbc.m115.711952;
RA   Kusevic D., Kudithipudi S., Jeltsch A.;
RT   "Substrate specificity of the HEMK2 protein glutamine methyltransferase and
RT   identification of novel substrates.";
RL   J. Biol. Chem. 291:6124-6133(2016).
RN   [12]
RP   VARIANT HIS-227.
RX   PubMed=24627108; DOI=10.1007/s00415-014-7289-8;
RA   Schabhuettl M., Wieland T., Senderek J., Baets J., Timmerman V.,
RA   De Jonghe P., Reilly M.M., Stieglbauer K., Laich E., Windhager R., Erwa W.,
RA   Trajanoski S., Strom T.M., Auer-Grumbach M.;
RT   "Whole-exome sequencing in patients with inherited neuropathies: outcome
RT   and challenges.";
RL   J. Neurol. 261:970-982(2014).
CC   -!- FUNCTION: May play a role in developmental myelination of peripheral
CC       nerves. {ECO:0000269|PubMed:14508709}.
CC   -!- INTERACTION:
CC       O15013; O15066: KIF3B; NbExp=3; IntAct=EBI-2515636, EBI-3931791;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O15013-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15013-6; Sequence=VSP_040757;
CC       Name=3;
CC         IsoId=O15013-7; Sequence=VSP_040754, VSP_040756;
CC       Name=4;
CC         IsoId=O15013-4; Sequence=VSP_010704;
CC       Name=5;
CC         IsoId=O15013-5; Sequence=VSP_040754, VSP_040755;
CC   -!- PTM: Methylated at Gln-1338 by N6AMT1. {ECO:0000269|PubMed:26797129}.
CC   -!- DISEASE: Slowed nerve conduction velocity (SNCV) [MIM:608236]: Affected
CC       individuals present a reduction in nerve conduction velocities without
CC       any clinical signs of peripheral or central nervous system dysfunction.
CC       SNCV inheritance is autosomal dominant. {ECO:0000269|PubMed:14508709}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH36809.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=AAH40474.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=BAA20754.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAH18365.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR749570; CAH18365.1; ALT_TERM; mRNA.
DR   EMBL; AB002292; BAA20754.2; ALT_INIT; mRNA.
DR   EMBL; AC019257; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC036809; AAH36809.1; ALT_SEQ; mRNA.
DR   EMBL; BC040474; AAH40474.1; ALT_SEQ; mRNA.
DR   EMBL; BC112926; AAI12927.1; -; mRNA.
DR   EMBL; AF009205; AAB71662.1; -; mRNA.
DR   CCDS; CCDS34794.1; -. [O15013-5]
DR   CCDS; CCDS78296.1; -. [O15013-6]
DR   CCDS; CCDS78297.1; -. [O15013-7]
DR   PIR; T03307; T03307.
DR   RefSeq; NP_001295081.1; NM_001308152.1. [O15013-7]
DR   RefSeq; NP_001295082.1; NM_001308153.1. [O15013-6]
DR   RefSeq; NP_055444.2; NM_014629.3. [O15013-5]
DR   RefSeq; XP_016869492.1; XM_017014003.1. [O15013-1]
DR   AlphaFoldDB; O15013; -.
DR   SMR; O15013; -.
DR   BioGRID; 114998; 103.
DR   IntAct; O15013; 22.
DR   STRING; 9606.ENSP00000340297; -.
DR   iPTMnet; O15013; -.
DR   PhosphoSitePlus; O15013; -.
DR   BioMuta; ARHGEF10; -.
DR   EPD; O15013; -.
DR   jPOST; O15013; -.
DR   MassIVE; O15013; -.
DR   MaxQB; O15013; -.
DR   PaxDb; O15013; -.
DR   PeptideAtlas; O15013; -.
DR   ProteomicsDB; 48364; -. [O15013-1]
DR   ProteomicsDB; 48365; -. [O15013-4]
DR   ProteomicsDB; 48366; -. [O15013-5]
DR   ProteomicsDB; 48367; -. [O15013-6]
DR   ProteomicsDB; 48368; -. [O15013-7]
DR   Antibodypedia; 8026; 181 antibodies from 31 providers.
DR   DNASU; 9639; -.
DR   Ensembl; ENST00000349830.8; ENSP00000340297.3; ENSG00000104728.16. [O15013-5]
DR   Ensembl; ENST00000398564.5; ENSP00000381571.1; ENSG00000104728.16. [O15013-1]
DR   Ensembl; ENST00000518288.5; ENSP00000431012.1; ENSG00000104728.16. [O15013-6]
DR   Ensembl; ENST00000520359.5; ENSP00000427909.1; ENSG00000104728.16. [O15013-7]
DR   Ensembl; ENST00000610399.4; ENSP00000481974.1; ENSG00000274726.4. [O15013-1]
DR   Ensembl; ENST00000619613.4; ENSP00000477988.1; ENSG00000274726.4. [O15013-5]
DR   Ensembl; ENST00000631758.1; ENSP00000488343.1; ENSG00000274726.4. [O15013-7]
DR   Ensembl; ENST00000633616.1; ENSP00000488463.1; ENSG00000274726.4. [O15013-6]
DR   GeneID; 9639; -.
DR   KEGG; hsa:9639; -.
DR   MANE-Select; ENST00000349830.8; ENSP00000340297.3; NM_014629.4; NP_055444.2. [O15013-5]
DR   UCSC; uc003wpr.4; human. [O15013-1]
DR   AGR; HGNC:14103; -.
DR   CTD; 9639; -.
DR   DisGeNET; 9639; -.
DR   GeneCards; ARHGEF10; -.
DR   GeneReviews; ARHGEF10; -.
DR   HGNC; HGNC:14103; ARHGEF10.
DR   HPA; ENSG00000104728; Low tissue specificity.
DR   MalaCards; ARHGEF10; -.
DR   MIM; 608136; gene.
DR   MIM; 608236; phenotype.
DR   neXtProt; NX_O15013; -.
DR   OpenTargets; ENSG00000104728; -.
DR   Orphanet; 140481; Autosomal dominant slowed nerve conduction velocity.
DR   PharmGKB; PA24967; -.
DR   VEuPathDB; HostDB:ENSG00000104728; -.
DR   eggNOG; KOG3522; Eukaryota.
DR   GeneTree; ENSGT00940000153798; -.
DR   InParanoid; O15013; -.
DR   OMA; NSDSEPX; -.
DR   OrthoDB; 2916834at2759; -.
DR   PhylomeDB; O15013; -.
DR   TreeFam; TF331430; -.
DR   PathwayCommons; O15013; -.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   Reactome; R-HSA-8980692; RHOA GTPase cycle.
DR   Reactome; R-HSA-9013026; RHOB GTPase cycle.
DR   Reactome; R-HSA-9013106; RHOC GTPase cycle.
DR   Reactome; R-HSA-9013148; CDC42 GTPase cycle.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   SignaLink; O15013; -.
DR   SIGNOR; O15013; -.
DR   BioGRID-ORCS; 9639; 11 hits in 1158 CRISPR screens.
DR   ChiTaRS; ARHGEF10; human.
DR   GeneWiki; ARHGEF10; -.
DR   GenomeRNAi; 9639; -.
DR   Pharos; O15013; Tbio.
DR   PRO; PR:O15013; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; O15013; protein.
DR   Bgee; ENSG00000104728; Expressed in sural nerve and 94 other tissues.
DR   ExpressionAtlas; O15013; baseline and differential.
DR   Genevisible; O15013; HS.
DR   GO; GO:0005813; C:centrosome; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:BHF-UCL.
DR   GO; GO:0019894; F:kinesin binding; IPI:BHF-UCL.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0090630; P:activation of GTPase activity; IDA:BHF-UCL.
DR   GO; GO:0051298; P:centrosome duplication; IMP:BHF-UCL.
DR   GO; GO:0090307; P:mitotic spindle assembly; IMP:BHF-UCL.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; IMP:BHF-UCL.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IMP:BHF-UCL.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; Dbl homology (DH) domain; 1.
DR   Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 1.
DR   InterPro; IPR039919; ARHGEF10/ARHGEF17.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR12877; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; 1.
DR   PANTHER; PTHR12877:SF14; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 10; 1.
DR   Pfam; PF19057; PH_19; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   Pfam; PF19056; WD40_2; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; DBL homology domain (DH-domain); 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF50978; WD40 repeat-like; 1.
DR   PROSITE; PS50010; DH_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Disease variant;
KW   Guanine-nucleotide releasing factor; Methylation; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..1369
FT                   /note="Rho guanine nucleotide exchange factor 10"
FT                   /id="PRO_0000080926"
FT   DOMAIN          421..608
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   REGION          1..106
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          184..254
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1226..1260
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1277..1297
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          304..355
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        192..206
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1226..1245
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1277..1295
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         180
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C033"
FT   MOD_RES         379
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         1287
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         1338
FT                   /note="N5-methylglutamine"
FT                   /evidence="ECO:0000269|PubMed:26797129"
FT   VAR_SEQ         1..24
FT                   /note="Missing (in isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9205841"
FT                   /id="VSP_040754"
FT   VAR_SEQ         185
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:9205841"
FT                   /id="VSP_040755"
FT   VAR_SEQ         307..345
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040756"
FT   VAR_SEQ         545
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_040757"
FT   VAR_SEQ         897..925
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:9314494"
FT                   /id="VSP_010704"
FT   VARIANT         227
FT                   /note="N -> H (found in a patient with hereditary motor and
FT                   sensory neuropathy; unknown pathological significance;
FT                   dbSNP:rs767902219)"
FT                   /evidence="ECO:0000269|PubMed:24627108"
FT                   /id="VAR_073288"
FT   VARIANT         357
FT                   /note="T -> I (in SNCV; dbSNP:rs28940281)"
FT                   /evidence="ECO:0000269|PubMed:14508709"
FT                   /id="VAR_019118"
FT   VARIANT         700
FT                   /note="V -> I (in dbSNP:rs2294039)"
FT                   /id="VAR_038603"
FT   VARIANT         725
FT                   /note="V -> I (in dbSNP:rs2294039)"
FT                   /id="VAR_057188"
FT   MUTAGEN         1338
FT                   /note="Q->R: Abolishes methylation by N6AMT1."
FT                   /evidence="ECO:0000269|PubMed:26797129"
FT   CONFLICT        395
FT                   /note="L -> F (in Ref. 5; AAI12927)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        500
FT                   /note="D -> V (in Ref. 5; AAH40474)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1024
FT                   /note="T -> S (in Ref. 6; AAB71662)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1046
FT                   /note="S -> T (in Ref. 6; AAB71662)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1369 AA;  151612 MW;  6F87869C7C6A5759 CRC64;
     MRPPGFLSRA PSLNRAERGI WSCSMDQREP LPPAPAENEM KYDTNNNEEE EGEQFDFDSG
     DEIPEADRQA PSAPETGGAG ASEAPAPTGG EDGAGAETTP VAEPTKLVLP MKVNPYSVID
     ITPFQEDQPP TPVPSAEEEN VGLHVPCGYL VPVPCGYAVP SNLPLLLPAY SSPVIICATS
     LDEEAETPEV TEDRQPNSLS SEEPPTSEDQ VGREDSALAR WAADPANTAW MENPEEAIYD
     DVPRENSDSE PDEMIYDDVE NGDEGGNSSL EYGWSSSEFE SYEEQSDSEC KNGIPRSFLR
     SNHKKQLSHD LTRLKEHYEK KMRDLMASTV GVVEIQQLRQ KHELKMQKLV KAAKDGTKDG
     LERTRAAVKR GRSFIRTKSL IAQDHRSSLE EEQNLFIDVD CKHPEAILTP MPEGLSQQQV
     VRRYILGSVV DSEKNYVDAL KRILEQYEKP LSEMEPKVLS ERKLKTVFYR VKEILQCHSL
     FQIALASRVS EWDSVEMIGD VFVASFSKSM VLDAYSEYVN NFSTAVAVLK KTCATKPAFL
     EFLKQEQEAS PDRTTLYSLM MKPIQRFPQF ILLLQDMLKN TSKGHPDRLP LQMALTELET
     LAEKLNERKR DADQRCEVKQ IAKAINERYL NKLLSSGSRY LIRSDDMIET VYNDRGEIVK
     TKERRVFMLN DVLMCATVSS RPSHDSRVMS SQRYLLKWSV PLGHVDAIEY GSSAGTGEHS
     RHLAVHPPES LAVVANAKPN KVYMGPGQLY QDLQNLLHDL NVIGQITQLI GNLKGNYQNL
     NQSVAHDWTS GLQRLILKKE DEIRAADCCR IQLQLPGKQD KSGRPTFFTA VFNTFTPAIK
     ESWVNSLQMA KLALEEENHM GWFCVEDDGN HIKKEKHPLL VGHMPVMVAK QQEFKIECAA
     YNPEPYLNNE SQPDSFSTAH GFLWIGSCTH QMGQIAIVSF QNSTPKVIEC FNVESRILCM
     LYVPVEEKRR EPGAPPDPET PAVRASDVPT ICVGTEEGSI SIYKSSQGSK KVRLQHFFTP
     EKSTVMSLAC TSQSLYAGLV NGAVASYARA PDGSWDSEPQ KVIKLGVLPV RSLLMMEDTL
     WAASGGQVFI ISVETHAVEG QLEAHQEEGM VISHMAVSGV GIWIAFTSGS TLRLFHTETL
     KHLQDINIAT PVHNMLPGHQ RLSVTSLLVC HGLLMVGTSL GVLVALPVPR LQGIPKVTGR
     GMVSYHAHNS PVKFIVLATA LHEKDKDKSR DSLAPGPEPQ DEDQKDALPS GGAGSSLSQG
     DPDAAIWLGD SLGSMTQKSD LSSSSGSLSL SHGSSSLEHR SEDSTIYDLL KDPVSLRSKA
     RRAKKAKASS ALVVCGGQGH RRVHRKARQP HQEELAPTVM VWQIPLLNI
//
